Magnetic resonance device with diffusion gradient phase variation positionally corrected
US-9097778-B2 · Aug 4, 2015 · US
US9404986B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9404986-B2 |
| Application number | US-201213466081-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 7, 2012 |
| Priority date | May 6, 2011 |
| Publication date | Aug 2, 2016 |
| Grant date | Aug 2, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods, devices and systems are disclosed for measuring biological tissue parameters using restriction spectrum magnetic resonance imaging. In one aspect, a method of characterizing a biological structure includes determining individual diffusion signals from magnetic resonance imaging (MRI) data in a set of MRI images that include diffusion weighting conditions (e.g., diffusion gradient directions, diffusion gradient strengths, sensitivity factors (b-values), or diffusion times), combining the individual diffusion signals to determine a processed diffusion signal corresponding to at least one location within one or more voxels of the MRI data, calculating one or more parameters from the processed diffusion signal by using the diffusion weighting conditions, and using the one or more parameters to identify a characteristic of the biological structure, in which the one or more parameters include values over a range of one or more diffusion length scales based on at least one of diffusion distance or diffusion rate.
Opening claim text (preview).
What is claimed is: 1. A method of characterizing a biological structure, comprising: determining individual diffusion signals from magnetic resonance imaging (MRI) data in a set of MRI images of a biological structure, the MRI data including diffusion weighting conditions that include at least one of diffusion gradient directions, diffusion gradient strengths, sensitivity factors (b-values), or diffusion times; combining the individual diffusion signals to determine a processed diffusion signal corresponding to at least one location within one or more voxels of the MRI data; calculating one or more parameters from the processed diffusion signal by using the diffusion weighting conditions; and using the one or more parameters to identify a characteristic of the biological structure, wherein the one or more parameters include values over a range of one or more diffusion length scales based on at least one of diffusion distance or diffusion rate. 2. The method of claim 1 , wherein each of the individual diffusion signals includes an orientation and a volume fraction. 3. The method of claim 1 , wherein the one or more diffusion length scales include fine scale diffusion processes occurring at one end and coarse scale diffusion processes occurring at the other end of each of the one or more diffusion length scales, wherein the fine scale diffusion processes include transverse diffusivities less than longitudinal diffusivities, and the coarse scale diffusion processes including transverse diffusivities greater than longitudinal diffusivities. 4. The method of claim 1 , wherein the one or more parameters include at least one of scaled volume fraction, fiber orientation distribution, compartment geometry, geometric tortuosity, or compartment diameter. 5. The method of claim 4 , wherein the fiber orientation distribution includes a hindered fiber orientation distribution (h-FOD) and restricted fiber orientation distribution (r-FOD), and the compartment geometry includes a cylindrical geometry. 6. The method of claim 5 , further comprising producing a model of a microstructure of the biological structure based on the fiber orientation distribution. 7. The method of claim 6 , wherein the model includes at least one of intra-cylindrical diffusivity values or extra-cylindrical diffusivity values of fibers within the biological structure. 8. The method of claim 7 , wherein the compartment geometry further includes a cylindrical geometry. 9. The method of claim 8 , wherein the model includes at least one of intra-spherical diffusivity values or extra-spherical diffusivity values of the spherical compartments within the biological structure. 10. The method of claim 8 , further comprising deriving cellularity index values over the range of the one or more diffusion length scales for each voxel of the one or more voxels. 11. The method of claim 10 , wherein the cellularity index values are derived based on maximizing sensitivity to the spherical compartments in the r-FOD. 12. The method of claim 5 , further comprising producing a tractography model of fiber tracts of the biological structure by using fractional anisotropy values. 13. The method of claim 3 , wherein the calculating includes fitting estimate values into a linear mixture model of the processed diffusion signal for a plurality of conditions of the diffusion weighting conditions. 14. The method of claim 13 , wherein the fitting includes using at least one of spherical harmonic functions or Bessel functions. 15. The method of claim 1 , wherein the biological structure includes at least one of cell bodies, axons, dendrites, cell processes, intracellular, or extracellular space. 16. The method of claim 1 , wherein the characteristic of the biological structure includes at least one of a categorization as a healthy or a diseased structure, severity of the diseased structure, shape, size, density, or orientation. 17. The method of claim 1 , wherein the values corresponding to the identified characteristic include a relative value compared to a normal value of the characteristic. 18. The method of claim 1 , further comprising forming an image of the identified characteristic at a particular diffusion length scale using the value of at least one of the one or more parameters at the corresponding diffusion length scale. 19. The method of claim 18 , further comprising forming a combined image of the identified characteristic from each of the formed images across the range of the one or more diffusion length scales. 20. The method of claim 13 , further comprising acquiring the MRI data by using a bias variance tradeoff in the linear mixture model. 21. An MRI system, comprising: a magnetic resonance imaging data acquisition system adapted to acquire magnetic resonance (MR) data from a biological structure of a subject, the MR data comprising one or more data voxels; and a data processing unit that receives the MR data from the magnetic resonance data imaging acquisition system, the data processing unit comprising: a mechanism that generates diffusion data of the biological structure from the MR data by determining a diffusion signal corresponding to at least one location within the one or more data voxels by combining a plurality of individual diffusion signals, each individual diffusion signal having an orientation and volume fraction, the diffusion data including one or more parameters, and a mechanism that uses the one or more parameters to identify a characteristic of the biological structure, wherein the one or more parameters include values over a range of one or more diffusion length scales based on at least one of diffusion distance or diffusion rate, and wherein the MR data includes at least one of diffusion gradient directions, diffusion gradient strengths, diffusion waveforms, diffusion sensitivity factors (b-values), or diffusion times. 22. The MRI system of claim 21 , wherein the one or more diffusion length scales include fine scale diffusion processes occurring at one end and coarse scale diffusion processes occurring at the other end of each of the one or more diffusion length scales, wherein the fine scale diffusion processes include transverse diffusivities less than longitudinal diffusivities, and the coarse scale diffusion processes including transverse diffusivities greater than longitudinal diffusivities. 23. The MRI system of claim 21 , wherein the one or more parameters include at least one of volume fraction, fiber orientation distribution, compartment geometry, geometric tortuosity, or compartment diameter. 24. The MRI system of claim 23 , wherein the fiber orientation distribution includes an h-FOD and an r-FOD, and the compartment geometry includes a cylindrical geometry. 25. The MRI system of claim 24 , wherein the data processing unit further comprises a mechanism that produces a model of a microstructure of the biological structure based on the fiber orientation distribution, the model including at least one of intra-cylindrical diffusivity values or extra-cylindrical diffusivity values of fibers within the biological structure. 26. The MRI system of claim 25 , wherein the compartment geometry further includes a cylindrical geometry, and the model further includes at least one of intra-spherical diffusivity values or extra-spherical diffusivity values of the spherical compartments within the biological structure.
Diffusion imaging · CPC title
NMR imaging systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.